Hikaru Okada

Global Medical Evidence Generation Lead
Sanofi, Tokyo, Japan
Tokyo, Tokyo, Japan

Presentation(s):

• PB0312 - Assessment of post-treatment anti-drug antibodies to caplacizumab in patients with immune-mediated thrombotic thrombocytopenic purpura

  Sunday, June 25, 2023
  18:30 – 19:30 ET